WASHINGTON (Reuters) - A drug once commonly used for emphysema and other forms of chronic obstructive pulmonary disease may raise the risk of heart death by a third, U.S. researchers reported on Tuesday.
WASHINGTON (Reuters) - A drug once commonly used for emphysema and other forms of chronic obstructive pulmonary disease may raise the risk of heart death by a third, U.S. researchers reported on Tuesday.
